Aimia Inc.
TSX:AIM-PA.TOChemicals - Specialty
+$0.00 today
- Market cap
- $552.64M
- Beta
- 0.14
- P/E (TTM)
- -19.0
- EPS (TTM)
- -$0.14
Volume 0.00M
Average 0.00M
AIM-PA.TO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Aimia Inc.TSX: AIM-PA.TO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month research & development was CA$0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CAD · from the income statement
- Latest · FY2025
- 0 CAD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How AIM-PA.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for AIM-PA.TO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AIM-PA.TOAimia Inc. | LTM Mar 2026 | CA$0 CAD | — | — | 0.0% |
| FY2025 | CA$0 CAD | — | — | 0.0% | |
| FY2025 | CA$0 CAD | — | — | 0.0% | |
QRC.TOQueen's Road Capital Investment Ltd. | LTM Feb 2026 | $0 USD | — | — | 0.0% |
| FY2025 | CA$0 CAD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| FY2025 | CA$0 CAD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Peer median (excluding AIM-PA.TO) | — | — | — | 0.0% | |
Competitors are the stored peer set for AIM-PA.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.6M | 477.8M | 203.1M | 500.8M | 503.4M |
| Cost of Revenue | 0 | 0 | 35.9M | 368.8M | 367.1M |
| Gross Profit | 12.6M | 477.8M | 167.2M | 132M | 136.3M |
| Gross Margin | 100.0% | 100.0% | 82.3% | 26.4% | 27.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 8.7M | 20.7M | 342.2M | 495.1M | 469.8M |
| Operating Expenses | 24.7M | 32.5M | 347.8M | 114.1M | 102.3M |
| Depreciation & Amortization | 700K | 100K | 22.9M | 35.4M | 36.8M |
| EBITDA | (11.4M) | 445.4M | (157.7M) | 30M | 70.8M |
| EBITDA Margin | -90.5% | 93.2% | -77.6% | 6.0% | 14.1% |
| Operating Income | (12.1M) | 445.3M | (180.6M) | 17.9M | 34M |
| Operating Margin | -96.0% | 93.2% | -88.9% | 3.6% | 6.8% |
| Interest Income | 1.6M | 5.7M | 14.2M | 16.6M | 7.7M |
| Interest Expense | 0 | 0 | 35.9M | 19.5M | 30.6M |
| Other Income / Expenses | 0 | 0 | 0 | (61.8M) | (38.8M) |
| Income Before Tax | (12.1M) | 445.3M | (180.6M) | (43.9M) | (4.8M) |
| Pre-Tax Margin | -96.0% | 93.2% | -88.9% | -8.8% | -1.0% |
| Income Tax Expense | 5M | 5.2M | 8M | 9.6M | 7.8M |
| Net Income | (16.4M) | 440.1M | (188M) | (56.4M) | (16.2M) |
| Net Margin | -130.2% | 92.1% | -92.6% | -11.3% | -3.2% |
| EPS (Basic) | (0.32) | 4.88 | (2.37) | (0.75) | 0.38 |
| EPS (Diluted) | (0.32) | 4.83 | (2.37) | (0.75) | 0.38 |
| Weighted Avg Shares | 90.92M | 87.68M | 84.69M | 95.36M | 92.45M |
| Weighted Avg Shares (Diluted) | 90.92M | 88.45M | 84.69M | 95.36M | 92.45M |
Aimia Inc.
TSX:AIM-PA.TO
Intrinsic Alpha fair value
Locked
Current Price
$22.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.